Preferred Label : sacituzumab govitecan;
Origin ID : M000618569;
Currated CISMeF NLP mapping
- MeSH narrower concept(s)
- Related record
https://www.has-sante.fr/jcms/p_3537214/fr/trodelvy-sacituzumab-govitecan-cancer-du-sein
2024
false
false
false
France
evaluation of the transparency committee
neoplasm, malignant
Sacituzumab Govitecan
Male Breast Carcinoma
sacituzumab govitecan
breast neoplasms
breast cancer
sacituzumab govitecan
Childhood Breast Carcinoma
---
